Therapeutic Asset Ratings
407 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TRASTUZUMAB
Breast Neoplasms
Merck Sharp & Dohme LLC
P3
BB
(68)
CIS-DIAMMINEDICHLOROPLATINUM II
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC
P2
BB
(68)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Neoplasms
Merck Sharp & Dohme LLC
P4
BB
(67)
CIS-DIAMMINEDICHLOROPLATINUM II
Biliary Tract Cancer
Merck Sharp & Dohme LLC
P3
BB
(67)
Docetaxel
Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(67)
Pembrolizumab
Merkel Cell Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(67)
PREDNISONE TABLETS
Neoplasm Metastasis
Merck Sharp & Dohme LLC
P3
BB
(67)
Capecitabine
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC
P2
BB
(67)
Efinopegdutide
Nonalcoholic Steatohepatitis
Merck Sharp & Dohme LLC
P2
BB
(67)
Favezelimab
Hodgkin Disease
Merck Sharp & Dohme LLC
P2
BB
(67)
(+)-VINCRISTINE
Cancer, Gall Bladder
Merck Sharp & Dohme LLC
P2
BB
(67)
Zofran
Follicular Lymphoma
Merck Sharp & Dohme LLC
P4
BB
(66)
Belzutifan
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
P3
BB
(66)
Epirubicin
Biliary Tract Cancer
Merck Sharp & Dohme LLC
P3
BB
(66)
Epirubicin
Bladder Cancer
Merck Sharp & Dohme LLC
P3
BB
(66)
Epirubicin
Stomach Neoplasms
Merck Sharp & Dohme LLC
P3
BB
(66)
human hyaluronidase isozyme-5 (HYAL5, sperm adhesion molecule 1, SPAM1, hyaluronidase PH-20, EC:3.2.1.35) fragment (3-433, 1-431 in the current sequence) engineered variant with the structural domain replaced by the corresponding region of human hyaluronidase isozyme-1 (HYAL1)(<sup>306</sup>TLSIMRSMKSCLLDDNYMETI<sup>326</sup>><sup>304</sup>SWENTRTKESCQAIKEYMDTT<sup>324</sup>), produced in Chinese hamster ovary (CHO) cells, cell line DG44, glycoform alfa
Metastatic Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
P3
BB
(66)
Pembrolizumab
Biliary Tract Cancer
Merck Sharp & Dohme LLC
P3
BB
(66)
Pembrolizumab
Stomach Neoplasms
Merck Sharp & Dohme LLC
P3
BB
(66)
Vibostolimab
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC
P3
BB
(66)
Docetaxel
Ovarian Neoplasms
Merck Sharp & Dohme LLC
P2
BB
(66)
Irinotecan
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(66)
Benadryl
Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Merck Sharp & Dohme LLC
P2/3
BB
(66)
FLUOROURACILUM
Esophageal Cancer
Merck Sharp & Dohme LLC
P4
BB
(65)
CIS-DIAMMINEDICHLOROPLATINUM II
Uterine Cervical Neoplasms
Merck Sharp & Dohme LLC
P3
BB
(65)
Showing 26 to 50 of 407 assets
Previous
Page 2 of 17
Next